Doug Cecchini
Advertisement
Articles by Doug Cecchini
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Spyre’s Anti-TL1A Antibody SPY072 Misses in Psoriatic Arthritis and Axial Spondyloarthritis, Shifts Focus to Hidradenitis Suppurativa
2
China Grants Ivonescimab Priority Review in Biliary Tract Cancer
3
T-Therapeutics Raises $133 Million to Take TCR Bispecifics Into the Clinic
4
The BioPharm Brief: Ivonescimab Priority Review in China, Stargardt Gene Therapy Moves Toward Phase 3, and Longer Dosing Intervals for an IBD Bispecific
5